Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George R Stark

Showing results (41-50 of 125) with videos related to

Pageof 13
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|July 22, 2015
Erlotinib protects against LPS-induced endotoxicity because TLR4 needs EGFR to signalSarmishtha De, Hao Zhou, David DeSantis, et al.
Oncogene|December 17, 2003
Secretion of cytokines and growth factors as a general cause of constitutive NFkappaB activation in cancerTao Lu, Swati S Sathe, Shannon M Swiatkowski, et al.
The Journal of Biological Chemistry|September 14, 2014
Critical role for lysine 685 in gene expression mediated by transcription factor unphosphorylated STAT3Maupali Dasgupta, Hamiyet Unal, Belinda Willard, et al.
British Journal of Cancer|December 1, 2020
CBL0137 increases the targeting efficacy of Rovalpituzumab tesirine against tumour-initiating cells in small cell lung cancerDaniel J Lindner, Gary Wildey, Yvonne Parker, et al.
The Journal of Biological Chemistry|August 10, 2002
Requirement of phosphoinositide 3-kinase and Akt for interferon-beta-mediated induction of the beta-R1 (SCYB11) geneM R Sandhya Rani, Linda Hibbert, Nywana Sizemore, et al.
Molecular and Cellular Biology|March 9, 2002
Stat1-dependent, p53-independent expression of p21(waf1) modulates oxysterol-induced apoptosisSudesh Agrawal, Munna L Agarwal, Moitreyee Chatterjee-Kishore, et al.
Cancer Research|February 15, 2018
The FACT inhibitor CBL0137 Synergizes with Cisplatin in Small-Cell Lung Cancer by Increasing <i>NOTCH1</i> Expression and Targeting Tumor-Initiating CellsSarmishtha De, Daniel J Lindner, Claire J Coleman, et al.
Cell Cycle (Georgetown, Tex.)|July 19, 2008
Transposon-based mutagenesis identifies short RIP1 as an activator of NFkappaBMaupali Dasgupta, Mukesh K Agarwal, Patrick Varley, et al.
Genes & Development|May 19, 2007
Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NFkappaBJinbo Yang, Xudong Liao, Mukesh K Agarwal, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 2, 2013
STAT3 activation in response to IL-6 is prolonged by the binding of IL-6 receptor to EGF receptorYuxin Wang, Anette H H van Boxel-Dezaire, HyeonJoo Cheon, et al.
Pageof 13

Showing results (41-50 of 125) with videos related to

Sort By:
Pageof 13
Proceedings of the National Academy of Sciences of the United States of America|July 22, 2015
Erlotinib protects against LPS-induced endotoxicity because TLR4 needs EGFR to signalSarmishtha De, Hao Zhou, David DeSantis, et al.
Oncogene|December 17, 2003
Secretion of cytokines and growth factors as a general cause of constitutive NFkappaB activation in cancerTao Lu, Swati S Sathe, Shannon M Swiatkowski, et al.
The Journal of Biological Chemistry|September 14, 2014
Critical role for lysine 685 in gene expression mediated by transcription factor unphosphorylated STAT3Maupali Dasgupta, Hamiyet Unal, Belinda Willard, et al.
British Journal of Cancer|December 1, 2020
CBL0137 increases the targeting efficacy of Rovalpituzumab tesirine against tumour-initiating cells in small cell lung cancerDaniel J Lindner, Gary Wildey, Yvonne Parker, et al.
The Journal of Biological Chemistry|August 10, 2002
Requirement of phosphoinositide 3-kinase and Akt for interferon-beta-mediated induction of the beta-R1 (SCYB11) geneM R Sandhya Rani, Linda Hibbert, Nywana Sizemore, et al.
Molecular and Cellular Biology|March 9, 2002
Stat1-dependent, p53-independent expression of p21(waf1) modulates oxysterol-induced apoptosisSudesh Agrawal, Munna L Agarwal, Moitreyee Chatterjee-Kishore, et al.
Cancer Research|February 15, 2018
The FACT inhibitor CBL0137 Synergizes with Cisplatin in Small-Cell Lung Cancer by Increasing <i>NOTCH1</i> Expression and Targeting Tumor-Initiating CellsSarmishtha De, Daniel J Lindner, Claire J Coleman, et al.
Cell Cycle (Georgetown, Tex.)|July 19, 2008
Transposon-based mutagenesis identifies short RIP1 as an activator of NFkappaBMaupali Dasgupta, Mukesh K Agarwal, Patrick Varley, et al.
Genes & Development|May 19, 2007
Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NFkappaBJinbo Yang, Xudong Liao, Mukesh K Agarwal, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 2, 2013
STAT3 activation in response to IL-6 is prolonged by the binding of IL-6 receptor to EGF receptorYuxin Wang, Anette H H van Boxel-Dezaire, HyeonJoo Cheon, et al.
Pageof 13